• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
3-Bromo-4-fluorobenzaldehyde
5-Methyl-1,3,4-oxadiazol2(3H)-one
4-Amino-6-methyl-3 oxo2,3, 4,5-tetrahydro 1.2.4-triazine hydrochloride
4-Acetylamino-6-methyl -3-oxo-2,3,4,5-tetrahydro-1,2,4-triazine
3-Pyridinecarboxaldehyde
Ethyl 3 Fluorobenzoate

India, China may start producing Sputnik V vaccine: Putin

expresspharmaNovember 18, 2020

Tag: COVID-19 , Sputnik V vaccine , china , India

India and China may start producing Russia’s Sputnik V vaccine against COVID-19, the RIA news agency cited President Vladimir Putin as saying.

Putin also proposed that the creation of a vaccine research centre for BRICS countries – Brazil, Russia, India, China and South Africa – be sped up, TASS reported.

Recently, RDIF and Gamaleya Institute had issued a statement claiming that as per interim trial results,  the Sputnik-V vaccine is 92 per cent effective at preventing COVID-19.

Previous:Foxx Life Sciences to open Asia headquarters in Medchal, Hyderabad

Next:T2D market will grow from a total of $48.1bn sales in 2019 to $91.9 bn in 2029

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

India, China may start producing Sputnik V vaccine: Putin | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

You may like
More>>

Toradol USP ≥98.5% API Pharmaceutical made in china

Toradol USP ≥98.5% API Pharmaceutical made in china
Echinacea Purpurea Extract

Echinacea Purpurea Extract
China professional factory High quality 999% FK-5-1-12 CAS 756-13-8 with fast delivery

China professional factory High quality 999% FK-5-1-12 CAS 756-13-8 with fast delivery
D-Methionine AJI92 Amino acid made in china

D-Methionine AJI92 Amino acid made in china
China factory direct supply Favorable Price Polyoxyethylene stearate with cas

China factory direct supply Favorable Price Polyoxyethylene stearate with cas
Cranberry Extract 25% PAC Plant Extract China Factory

Cranberry Extract 25% PAC Plant Extract China Factory
Betamethasone Sodium Phosphate USP API Hormone made in china

Betamethasone Sodium Phosphate USP API Hormone made in china
Echinacea Herb Extract

Echinacea Herb Extract
Echinacea Purpurea Extract Powder10:1

Echinacea Purpurea Extract Powder10:1
Echinacea Root Powder

Echinacea Root Powder

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service